Clinical trial
Pharmacokinetic and Safety Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function
NCT07457190 is registered in ClinicalTrials.gov with Beijing Union Pharmaceutical Factory Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic and Safety Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function
- Lead sponsor
- Beijing Union Pharmaceutical Factory Ltd
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- March 31, 2026
- Completion date
- December 31, 2026
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.